Ozan Cem Güler

1.6k total citations
118 papers, 1.1k citations indexed

About

Ozan Cem Güler is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Obstetrics and Gynecology. According to data from OpenAlex, Ozan Cem Güler has authored 118 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 34 papers in Radiology, Nuclear Medicine and Imaging and 33 papers in Obstetrics and Gynecology. Recurrent topics in Ozan Cem Güler's work include Prostate Cancer Treatment and Research (33 papers), Endometrial and Cervical Cancer Treatments (32 papers) and Prostate Cancer Diagnosis and Treatment (31 papers). Ozan Cem Güler is often cited by papers focused on Prostate Cancer Treatment and Research (33 papers), Endometrial and Cervical Cancer Treatments (32 papers) and Prostate Cancer Diagnosis and Treatment (31 papers). Ozan Cem Güler collaborates with scholars based in Türkiye, United States and Cyprus. Ozan Cem Güler's co-authors include Cem Önal, Berna Akkuş Yıldırım, Mehmet Reyhan, Ezgi Oymak, Gürcan Erbay, Ali Fuat Yapar, Neşe Torun, Erkan Topkan, Hüseyin Mertsoylu and Cem Parlak and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ozan Cem Güler

111 papers receiving 1.1k citations

Peers

Ozan Cem Güler
Kristin Bradley United States
Young Seok Kim South Korea
C. Durdux France
Christina H. Son United States
Zachary D. Horne United States
Kristin Bradley United States
Ozan Cem Güler
Citations per year, relative to Ozan Cem Güler Ozan Cem Güler (= 1×) peers Kristin Bradley

Countries citing papers authored by Ozan Cem Güler

Since Specialization
Citations

This map shows the geographic impact of Ozan Cem Güler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ozan Cem Güler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ozan Cem Güler more than expected).

Fields of papers citing papers by Ozan Cem Güler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ozan Cem Güler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ozan Cem Güler. The network helps show where Ozan Cem Güler may publish in the future.

Co-authorship network of co-authors of Ozan Cem Güler

This figure shows the co-authorship network connecting the top 25 collaborators of Ozan Cem Güler. A scholar is included among the top collaborators of Ozan Cem Güler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ozan Cem Güler. Ozan Cem Güler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Güler, Ozan Cem, et al.. (2025). Impact of Adjuvant Radiotherapy and Mitotane on Survival in Localized Adrenocortical Carcinoma: A Retrospective Cohort Study. International Journal of Urology. 33(1). e70319–e70319.
3.
Sutera, Philip, Jongmyung Kim, Ritesh Kumar, et al.. (2024). PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer. The Prostate. 84(14). 1301–1308. 2 indexed citations
4.
Yavaş, Güler, Ozan Cem Güler, Melis Gültekin, et al.. (2023). Multi-institutional study on the role of post-operative radiotherapy in elderly patients with endometrial cancer. International Journal of Gynecological Cancer. 33(5). 719–726. 2 indexed citations
5.
Güler, Ozan Cem, Ezgi Oymak, Gözde Yazıcı, et al.. (2023). Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 31(3). 299–306. 1 indexed citations
6.
Önal, Cem, Ozan Cem Güler, Neşe Torun, Ezgi Oymak, & Mehmet Reyhan. (2023). The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [68Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 50(12). 3755–3764. 1 indexed citations
7.
Önal, Cem, Ezgi Oymak, Ozan Cem Güler, et al.. (2022). Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study. Strahlentherapie und Onkologie. 199(5). 456–464. 3 indexed citations
8.
Topkan, Erkan, Yurday Özdemir, Ahmet Küçük, et al.. (2020). Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy. Journal of Oncology. 2020. 1–10. 7 indexed citations
9.
Gültekin, Melis, Ozan Cem Güler, Sezin Yüce Sarı, et al.. (2020). Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging. Journal of Obstetrics and Gynaecology. 41(3). 414–420. 7 indexed citations
10.
Önal, Cem, et al.. (2020). The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer. The Breast. 54. 197–202. 5 indexed citations
11.
Önal, Cem, Melis Gültekin, Ezgi Oymak, et al.. (2020). Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis. International Journal of Gynecological Cancer. 30(6). 865–872. 12 indexed citations
13.
Sarı, Sezin Yüce, Ozan Cem Güler, Melis Gültekin, Cem Önal, & Ferah Yıldız. (2017). Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient?. Oncology Research and Treatment. 40(9). 523–527. 4 indexed citations
14.
Önal, Cem, Neşe Torun, Ozan Cem Güler, & Berna Akkuş Yıldırım. (2016). Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy. Nuclear Medicine Communications. 37(12). 1282–1289. 3 indexed citations
15.
Birdir, Kemal, et al.. (2015). Hüzün Turizmi: Gelibolu Yarımadası Tarihi Milli Parkını Ziyaret Eden YabancıTuristlerinDeneyimleri. Journal of Tourism and Gastronomy Studies. 3(4). 12–23. 3 indexed citations
16.
Güler, Ozan Cem, et al.. (2015). Graves’ ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature. Wiener klinische Wochenschrift. 128(7-8). 299–303. 1 indexed citations
18.
Topkan, Erkan, Berna Akkuş Yıldırım, Ozan Cem Güler, et al.. (2015). Safety and Palliative Efficacy of Single-Dose 8-Gy Reirradiation for Painful Local Failure in Patients With Stage IV Non-Small Cell Lung Cancer Previously Treated With Radical Chemoradiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 91(4). 774–780. 6 indexed citations
19.
Güler, Ozan Cem, et al.. (2013). Endometrial Adenosarcoma: Case Report. 1(1). 1 indexed citations
20.
Önal, Cem, et al.. (2013). Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy. British Journal of Radiology. 87(1034). 20130617–20130617. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026